Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT00743886

Influence of Plasma Rich in Growth Factors (PRGF) on Healing of Medial Collateral Ligament (MCL) Tear

Influence of PRGF on Healing of MCL Tear - Randomized-Double-Blind-Placebo Control Trail

Status
Withdrawn
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Meir Medical Center · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

To evaluate the influence of Plasma Rich in Growth Factors (PRGF) on the healing process of medial collateral ligament (MCL) tear.

Detailed description

Autologous platelet-rich matrices may aid in the healing of ligaments \& tendons by promoting and accelerating tissue healing because of the release of growth factors including transforming growth factor (TGF)-beta1 and platelet-derived growth factor (PDGF) from platelet alpha-granules.

Conditions

Interventions

TypeNameDescription
BIOLOGICALPlasma Rich in Growth Factors (PRGF)injection onto injured area in ligament dose: 3-6mg
DRUGsalineinjection of 6 cc of saline into injured area

Timeline

Start date
2008-01-01
Primary completion
2009-02-01
Completion
2009-03-01
First posted
2008-08-29
Last updated
2011-07-12

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT00743886. Inclusion in this directory is not an endorsement.

Influence of Plasma Rich in Growth Factors (PRGF) on Healing of Medial Collateral Ligament (MCL) Tear (NCT00743886) · Clinical Trials Directory